AI Stock Picks — S&P 500

Monday, September 28, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Cautious  Normal choppiness · VIX 16.1

The broader index is in a sharp, broad-based selloff with the vast majority of constituents down double digits over the past day and week, indicating a high-volatility, risk-off regime rather than a stock-picker's market. A narrow group of names — mostly life-science instrumentation/diagnostics, select mega-cap tech, and cybersecurity software — are holding within low single digits of their 52-week highs and showing genuine positive 5-day and 30-day momentum, making them the more credible near-term bounce/continuation candidates.

Broad market drawdown with most S&P 500 names down 5-25% over the past day/week, favoring only names showing true relative strengthLife-science tools and diagnostics (instrumentation, CROs, genomics) standing out as a pocket of sustained strength near 52-week highsSelective mega-cap tech and cybersecurity/software names decoupling from the broader decline on continued AI/security demand narrativesElevated single-day volatility suggests idiosyncratic, name-specific catalysts (earnings, trial/regulatory news, M&A) rather than a market-wide bid

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 1
0%
57 · 247.2%
247.2% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 PFE SKIP — $28.72 → $30.24
stop $27.08
 Position cap reached — 57 of 20 slots in use.

Already open: IMI.L (to Sep 30), HSX.L (to Oct 1), LSEG.L (to Oct 1), ADM (to Oct 2), BEZ.L (to Oct 2), BIIB (to Oct 3), DE (to Oct 3), ELV (to Oct 4), HSBA.L (to Oct 7), ITRK.L (to Oct 8), SDR.L (to Oct 9), VOD.L (to Oct 9) … and 45 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
8 picks
Blaze
8 picks
Nova
3 picks
Orion
5 picks
Quinn
7 picks

1 Stock Pick

#1 PFEPfizer Inc.
3/5 Agents Agree  Risk 4/10
Moderate conviction · 59%

Pfizer is a major pharmaceutical company known for vaccines and a broad drug portfolio. The stock has quietly built positive momentum, and unlike many peers, its own CEO and directors have recently bought shares with their own money, a vote of confidence. The main risk is that the move so far has been modest, so it needs continued buying to reach the target.

Stop-loss$27.08-5.7%
Today's price$28.72
Target$30.24+5.3%
Agents estimate: $30.31 (+0.2% vs target)
If you invested $1,000
▲$1,053 if the target hits (+5.3%)
▼$943 if the stop-loss is hit (-5.7%)
The AI puts the chance of the win case at 59%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price ($28.72) is sitting right at the upper Bollinger Band ($29.05) and only 1.68% below the 52-week high, with RSI at 66.65 — this is a stretched entry near resistance, not the 'room to run' the thesis claims, and raises the odds of a mean-reversion pullback rather than continuation.
  • The MACD 'confirmation' is razor-thin: histogram of just 0.0221 (line 0.3127 vs signal 0.2906) indicates momentum is flattening rather than accelerating, undercutting the bullish MACD narrative.
  • The finance_data shows zero news articles and no corroborating source for the cited CEO/director insider buying or the guidance raise — these specific catalysts are unverifiable from the data provided and shouldn't be taken at face value.
Show the detailed analysis

Calibrated probability: 59% (raw model estimate: 72%) — adjusted using the accuracy of past resolved picks.

Trade math

0.9:1
52%
+2.2%
7%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
72%
Very High
Blaze
82%
Very High
Nova
—
—
Price gains are modest and trading volume is below average, despite some positive insider buying — not enough momentum to support a 5% target
Orion
—
—
Traditional pharma outside the favored sectors, with only a small overall price gain in the past month.
Quinn
62%
High

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 28, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by October 28, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • MTDMettler-Toledo International Inc.Liquidity filter
    Scout: Essentially at its 52-week high with strong 5-day and 30-day gains, showing rare sustained strength as the broader market sells off.
    20-day average daily volume 217,903 shares is below the 500,000-share liquidity floor.
  • TECHBio-Techne CorporationDropped at merge
    Scout: Flat and stable right at its 52-week high while peers collapse, signaling resilient demand and low downside pressure.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 72% raw (59% after calibration)).
  • WATWaters CorporationDropped at merge
    Scout: Within 1% of its 52-week high with a strong 30-day gain, indicating durable buying interest in lab instrumentation.
    Average probability across the 5 agent(s) that selected it was 68% raw (55% after calibration), below the 58% minimum to qualify.
  • AAgilent Technologies, Inc.Dropped at merge
    Scout: Double-digit 5-day and 30-day gains and essentially at its 52-week high, among the strongest momentum names in the index.
    Average probability across the 3 agent(s) that selected it was 67% raw (55% after calibration), below the 58% minimum to qualify.
  • RVTYRevvity, Inc.Already held
    Scout: Sharp double-digit 30-day rally with the stock sitting within 1% of its 52-week high, showing accelerating strength.
    Already held: a position opened 2026-09-16 runs until 2026-10-16 (18 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TMOThermo Fisher Scientific Inc.Already held
    Scout: Near its 52-week high with steady double-digit 30-day gains, a large, liquid name showing genuine relative strength.
    Already held: a position opened 2026-09-17 runs until 2026-10-17 (19 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • BIIBBiogen Inc.Already held
    Scout: Trading close to its 52-week high with consistent 5-day and 30-day gains, bucking the broader healthcare weakness.
    Already held: a position opened 2026-09-03 runs until 2026-10-03 (5 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • VTRSViatris Inc.Dropped at merge
    Scout: Strong 5-day and 30-day momentum and a fresh multi-day surge puts it right at its 52-week high.
    Average probability across the 4 agent(s) that selected it was 66% raw (55% after calibration), below the 58% minimum to qualify.
  • ILMNIllumina, Inc.Dropped at merge
    Scout: Sharp recent rally with a large one-day jump and the stock now only ~2% off its 52-week high, suggesting a genuine catalyst-driven re-rating.
    Average probability across the 2 agent(s) that selected it was 68% raw (55% after calibration), below the 58% minimum to qualify.
  • IQVIQVIA Holdings Inc.Already held
    Scout: Consistently positive across the 5-day and 30-day windows and close to its 52-week high, a steadier name amid the drawdown.
    Already held: a position opened 2026-09-24 runs until 2026-10-24 (26 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • GILDGilead Sciences, Inc.Dropped at merge
    Scout: Holding near its 52-week high with positive short and medium-term returns, showing defensive relative strength.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 67% raw (55% after calibration)).
  • JNJJohnson & JohnsonPassed over
    Scout: One of the few large caps near its 52-week high with steady positive momentum, offering a lower-volatility momentum play.
    Aria: Trading volume isn't confirming the price rise and the next earnings report lands in just 15 days, well inside the holding window, adding event risk on top of an already borderline momentum score.
    Blaze: Only a modest 1.6% earnings beat with no clear guidance raise visible, its next earnings report falls inside the 30-day window, and insiders have been selling heavily.
    Nova: Very muted price action (up just 0.9% in 5 days) — nothing suggesting a near-term 5% move
    Orion: A broad healthcare conglomerate rather than the specific instrumentation/diagnostics niche in focus, and its own price gain has been modest.
    Quinn: A Bollinger squeeze is present but the MACD histogram is negative and trading volume is diverging from price, a distribution warning sign.
  • PFEPfizer Inc.Picked #1
    Scout: Near its 52-week high with a positive 5-day pop, showing early signs of a turn higher against the market trend.
    Made the final report at #1.
  • WSTWest Pharmaceutical Services, Inc.Dropped at merge
    Scout: Within 3% of its 52-week high after a strong one-day and 30-day advance, indicating sustained buying interest.
    Average probability across the 3 agent(s) that selected it was 65% raw (55% after calibration), below the 58% minimum to qualify.
  • NVDANVIDIA CorporationAlready held
    Scout: Staying within roughly 3% of its 52-week high despite the market-wide rout, reflecting durable AI-driven demand.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AAPLApple Inc.Already held
    Scout: Trading near its 52-week high with a positive 30-day return, one of the most resilient mega caps in the current tape.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CRWDCrowdStrike Holdings, Inc.Already held
    Scout: Close to its 52-week high with strong 5-day and 30-day gains, benefiting from continued security-spend demand.
    Already held: a position opened 2026-09-23 runs until 2026-10-23 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • PANWPalo Alto Networks, Inc.Already held
    Scout: Near its 52-week high with steady positive short-term momentum, a relative-strength leader in cybersecurity.
    Already held: a position opened 2026-09-16 runs until 2026-10-16 (18 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • KEYSKeysight Technologies, Inc.Already held
    Scout: Sharp 5-day and 30-day gains keep it within 4% of its 52-week high, suggesting a real demand-driven move.
    Already held: a position opened 2026-09-23 runs until 2026-10-23 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AMEAMETEK, Inc.Dropped at merge
    Scout: Consistent gains across both windows and proximity to its 52-week high mark it as a steady industrial outperformer.
    Average probability across the 4 agent(s) that selected it was 67% raw (55% after calibration), below the 58% minimum to qualify.
  • FTNTFortinet, Inc.Already held
    Scout: Trading within 3% of its 52-week high with positive momentum, another security name showing relative resilience.
    Already held: a position opened 2026-09-24 runs until 2026-10-24 (26 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • DEDeere & CompanyAlready held
    Scout: Close to its 52-week high with a solid one-day and 30-day advance, an outlier of strength in industrials.
    Already held: a position opened 2026-09-03 runs until 2026-10-03 (5 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TERTeradyne, Inc.Dropped at merge
    Scout: Strong double-digit 5-day and 30-day gains reflect renewed semiconductor test-equipment demand, though further from its high and more volatile.
    Average probability across the 2 agent(s) that selected it was 66% raw (55% after calibration), below the 58% minimum to qualify.
  • DDOGDatadog, Inc.Already held
    Scout: Sharp 5-day acceleration on top of solid 30-day gains, a software name showing continued momentum despite sector-wide pressure.
    Already held: a position opened 2026-09-25 runs until 2026-10-25 (27 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • METAMeta Platforms, Inc.Dropped at merge
    Scout: A large 30-day surge keeps it within single digits of its 52-week high, showing strong buyer conviction even as the broader market fell.
    Average probability across the 3 agent(s) that selected it was 63% raw (55% after calibration), below the 58% minimum to qualify.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.